Reduced Medical Expenditures with Tofacitinib in Patients with Inadequate Response to Other RA Therapies
Tampa, FL—Post-hoc analyses of the phase 3 trials, ORAL Standard and ORAL Step, revealed that tofacitinib––a novel oral Janus kinase inhibitor––and adalimumab led to lower monthly medical expenditures (MMEs) compared with placebo in patients with moderate-to-severe rheumatoid arthritis (RA) who did not respond to either methotrexate or tumor necrosis factor (TNF) inhibitors, according to investigators Regina Rendas-Baum, MS, scientist at QualityMetric, and colleagues.
Paris, France—Nonadherence to medications is widespread in rheumatologic diseases, but the literature is sparse as to how this impacts healthcare outcomes and costs, according to speakers at the 2014 European League Against Rheumatism Congress.
Paris, France—Musculoskeletal conditions (MSKCs), which consist of approximately 150 different diseases, are the main driver of healthcare costs, according to a Dutch study presented at the 2014 European League Against Rheumatism (EULAR) Congress.
Philadelphia, PA—Neurologists are amidst a social transformation that threatens their professionalism, their ethical foundation, and their patients, said James L. Bernat, MD, Professor of Neurology and of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Earlier Use of Adjunctive Antiepileptic Drugs in Patients with Refractory Disease Could Reduce Costs
Philadelphia, PA—Changing from monotherapy to the early initiation of adjunctive therapy with a second antiepileptic drug in patients with partial-onset seizures may lead to a substantial reduction in healthcare utilization and costs, according to a retrospective claims database analysis presented in a poster at the 2014 American Academy of Neurology meeting.
Patients with stroke often require extensive inpatient and outpatient care that is associated with high expenditures and very high morbidity and mortality rates. Neuroimaging is an important component of care in patients with acute ischemic stroke, especially for guiding the use of thrombolysis. Imaging is associated with high costs and is being used more often today.
Page 3 of 8
Results 21 - 30 of 75
Results 21 - 30 of 75